AzTrials
AzTrials

AgingNCT06269939

Theory-Driven Manualized Approach to Improving New Learning and Memory in Healthy Aging and MCI

A study testing STEM in people with Aging, run by Kessler Foundation at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this research study is to investigate the effectiveness of a memory enhancement technique in an aging population. Read more about this study

Who is it for?
Ages 60 years and olderHealthy volunteers can take part
Conditions the study is for
Aging
What is being tested?
STEM
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
40 participants
Where
1 siteUnited States
Study dates
15 Dec 2025to 30 Mar 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • read and speak English fluently

Who cannot join

  • prior stroke or neurological injury/disease (i.e. traumatic brain injury, Multiple Sclerosis, or Stroke).
  • history of significant psychiatric illness (for example, bipolar disorder, schizophrenia, or psychosis).
  • significant alcohol or drug abuse history (inpatient treatment).
  • Benzodiazepines and steroid use
  • Diagnosis of dementia

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site, 1 recruiting
  • Kessler Foundation

    East Hanover, New Jersey, 07936

    Nancy Moore, 973-324-8450, nbmoore@kesslerfoundation.org

    Recruiting

Other trials in United States

About this study

Official title: Evaluation of a Theory-Driven Manualized Approach to Improving New Learning and Memory in Healthy Aging and Mild Cognitive Impairment

The purpose of this research study is to investigate the effectiveness of a memory enhancement technique in an aging population.

Read the detailed description

Memory enhancing techniques have been incorporated into an 8-session treatment protocol, Strategy Based Training to Enhance Memory (STEM), designed to teach participants about each of the techniques, train them on how to apply the techniques in daily life and practice their application to daily life memory demanding situations. The protocol includes teaching participants over age 60 how to restructure a memory demanding situation in order to make optimal use of the techniques.

Conditions
Aging
Being tested
STEM
Keywords
memory

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • STEMBehavioural

    Memory technique training

Study groups in NCT06269939
Study groupRoleWhat they receive
Experimental groupExperimentalThe experimental group will receive memory techniques training administered twice a week for four weeks (8 training sessions).
Receives: Behavioral: STEM
Control groupPlacebo comparatorThe control group will receive memory exercises administered twice a week for four weeks (8 sessions).
Receives: Behavioral: STEM

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Verbal Leaning task

    Change in total score from Open-Trial Selective Reminding Test (OT-SRT)

    Measured: Three points in time: pre-treatment, immediately following treatment, and 6- months after treatment is completed]

  2. Participation in Everyday life

    Change in total score from Participation Assessment with Recombined Tools

    Measured: Three points in time: pre-treatment, immediately following treatment, and 6- months after treatment is completed]

Secondary outcomes (1)
  1. Functional Neuroimaging

    Change in total scores from memory task during fMRI scan

    Measured: Two points in time: pre-treatment, immediately following treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Feb 2024
  2. Study start15 Dec 2025
  3. Primary completion30 Mar 2027 (estimated)
  4. Study completion30 Mar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06269939
Sponsor's protocol ID
R-1253-24
Status last verified
Jul 2026
First submitted
13 Feb 2024
Last updated
22 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing STEM in people with Aging, run by Kessler Foundation at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 22 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Nancy Moore (19733248450, nbmoore@kesslerfoundation.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Verbal Leaning task (time frame: Three points in time: pre-treatment, immediately following treatment, and 6- months after treatment is completed]). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jul 2026; AzTrials last refreshed its copy on 28 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in